FGL2 and cancer: Since accumulating evidence has demonstrated the potential of FGL2 as a therapeutic target and biomarker [18,20,24,29,31,32], the secretion of FGL2 by activated platelets at the cancer environment should also be taken into account in cancer research and therapeutics [33,53].